XML 27 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 68,903 $ 50,495
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19,721 16,397
Amortization of other deferred charges 4,207 0
Amortization of deferred revenue (1,095) (1,004)
Amortization of deferred financing costs and debt discount 1,984 1,438
Accretion of asset retirement obligations 267 219
Deferred income taxes 0 158
Income from equity method investments (4,681) (3,005)
Dividends from equity method investments 5,128 765
Loss on asset disposals 648 2
Unit-based compensation expense 518 545
Changes in assets and liabilities:    
Accounts receivable 1,198 (1,115)
Inventories and other current assets 17,022 2,028
Accounts payable and other current liabilities (4,311) 8,501
Accounts receivable/payable to related parties (50,030) 2,092
Non-current assets and liabilities, net (1,879) (365)
Net cash provided by operating activities 57,600 77,151
Cash flows from investing activities:    
Asset acquisitions, net of assumed ARO liabilities (72,222) (6,443)
Purchases of property, plant and equipment (8,674) (9,187)
Proceeds from sales of property, plant and equipment 465 0
Purchases of intangible assets (144,219) (2,560)
Distributions from equity method investments 957 753
Equity method investment contributions (172) (3,531)
Net cash used in investing activities (223,865) (20,968)
Cash flows from financing activities:    
Proceeds from issuance of additional units to maintain 2% General Partner interest 20 21
Distributions to general partner (17,010) (12,839)
Distributions to common unitholders - public (20,500) (19,208)
Distributions to common unitholders - Delek (34,335) (31,555)
Distributions to Delek unitholders and general partner related to Big Spring Logistic Assets Acquisition (98,798) 0
Proceeds from revolving credit facility 678,000 205,700
Payments of revolving credit facility (324,700) (439,500)
Proceeds from issuance of senior notes 0 248,112
Deferred financing costs paid (5,264) (5,937)
Reimbursement of capital expenditures by Delek 3,183 4,254
Net cash provided by (used in) financing activities 180,596 (50,952)
Net increase in cash and cash equivalents 14,331 5,231
Cash and cash equivalents at the beginning of the period 4,675 59
Cash and cash equivalents at the end of the period 19,006 5,290
Cash paid during the period for:    
Interest 24,446 9,288
Income taxes 136 60
Non-cash investing activities:    
Decrease in accrued capital expenditures (1,836) (491)
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 0 $ 67